Vanguard Portfolio Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Vanguard Portfolio Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$632K	Buy	+337,748	New	+$892K	﹤0.01%	3038

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Vanguard Portfolio Management's NAUT Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 337,748 shares worth $632K. The stake represents ﹤0.01% of the portfolio and ranks #3038 among its holdings.

92 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Vanguard Portfolio Management held 337,748 shares of Nautilus Biotechnolgy worth $632K as of Q2 2026.
Nautilus Biotechnolgy was a new Vanguard Portfolio Management position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3038 holding.
92 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.